Healthequity (HQY) Depreciation & Amortization (CF) (2013 - 2026)

Healthequity's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $38.2 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 1.36% year-over-year to $38.2 million; the TTM figure through Apr 2026 stood at $154.1 million (down 5.01% YoY), while the FY2026 annual figure was $154.7 million, down 4.8% from the prior year.
• Depreciation & Amortization (CF) for Q2 2026 stood at $38.2 million, down from $38.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $43.6 million in Q3 2024, with the low at $37.8 million in Q4 2023.
• The 5-year median for Depreciation & Amortization (CF) is $38.9 million (2022), against an average of $39.4 million.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) advanced 27.63% in 2022, then declined 11.82% in 2025.
• Healthequity's Depreciation & Amortization (CF) stood at $40.5 million in 2022, then declined by 6.72% to $37.8 million in 2023, then gained by 7.78% to $40.7 million in 2024, then dropped by 4.77% to $38.8 million in 2025, then fell by 1.46% to $38.2 million in 2026.
• Business Quant data shows HQY's Depreciation & Amortization (CF) at $38.2 million in Q2 2026, $38.7 million in Q1 2026, and $38.8 million in Q4 2025.